Literature DB >> 34517767

Multiple Chronic Conditions Explain Ethnic Differences in Functional Outcome Among Patients With Ischemic Stroke.

Xiaqing Jiang1, Lewis B Morgenstern1,2, Christine T Cigolle3,4, Lu Wang5, Edward S Claflin2,6, Lynda D Lisabeth1,2.   

Abstract

BACKGROUND AND
PURPOSE: Mexican Americans (MAs) have worse stroke outcomes and a different profile of multiple chronic conditions (MCC) compared with non-Hispanic White people. MCC has implications for stroke treatment, complications, and poststroke care, which impact poststroke functional outcome (FO). We sought to assess the contribution of MCC to the ethnic difference in FO at 90 days between MAs and non-Hispanic White people.
METHODS: In a prospective cohort of ischemic stroke patients (2008-2016) from Nueces County, Texas, data were collected from patient interviews, medical records, and hospital discharge data. MCC was assessed using a stroke-specific and function-relevant index (range, 0-35; higher scores greater MCC burden). Poststroke FO was measured by an average score of 22 activities of daily living (ADLs) and instrumental ADLs at 90 days (range, 1-4; higher scores worse FO). The contribution of MCC to the ethnic difference in FO was assessed using Tobit regression. Effect modification by ethnicity was examined.
RESULTS: Among the 896 patients, 70% were MA and 51% were women. Mean age was 68±12.2 years; 33% of patients were dependent in ADL/instrumental ADLs (FO score >3, representing a lot of difficulty with ADL/instrumental ADLs) at 90 days. MAs had significantly higher age-adjusted MCC burden compared with non-Hispanic White people. Patients with high MCC score (at the 75th percentile) on average scored 0.70 points higher in the FO score (indicating worse FO) compared with those with low MCC score (at the 25th percentile) after adjusting for age, initial National Institutes of Health Stroke Scale, and sociodemographic factors. MCC explained 19% of the ethnic difference in FO, while effect modification by ethnicity was not statistically significant.
CONCLUSIONS: MAs had a higher age-adjusted MCC burden, which partially explained the ethnic difference in FO. The prevention and treatment of MCC could potentially mitigate poststroke functional impairment and lessen ethnic disparities in stroke outcomes.

Entities:  

Keywords:  comorbidity; ethnic groups; multiple chronic conditions; prognosis; stroke

Mesh:

Year:  2021        PMID: 34517767      PMCID: PMC8712371          DOI: 10.1161/STROKEAHA.120.032595

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  46 in total

1.  Robust causal inference using directed acyclic graphs: the R package 'dagitty'.

Authors:  Johannes Textor; Benito van der Zander; Mark S Gilthorpe; Maciej Liskiewicz; George Th Ellison
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

2.  Does pre-existing cognitive impairment no-dementia influence the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia?

Authors:  Kei Murao; Marie Bodenant; Charlotte Cordonnier; Stéphanie Bombois; Hilde Hénon; Florence Pasquier; Régis Bordet; Didier Leys
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-02       Impact factor: 10.154

3.  Effects of premorbid physical activity on stroke severity and post-stroke functioning.

Authors:  Marie Helene Ursin; Hege Ihle-Hansen; Brynjar Fure; Arnljot Tveit; Astrid Bergland
Journal:  J Rehabil Med       Date:  2015-08-18       Impact factor: 2.912

4.  Cerebrovascular reactivity is impaired in patients with cardiac failure.

Authors:  D Georgiadis; M Sievert; S Cencetti; F Uhlmann; M Krivokuca; S Zierz; K Werdan
Journal:  Eur Heart J       Date:  2000-03       Impact factor: 29.983

5.  Discharge destination's effect on bounce-back risk in Black, White, and Hispanic acute ischemic stroke patients.

Authors:  Amy J H Kind; Maureen A Smith; Jinn-Ing Liou; Nancy Pandhi; Jennifer R Frytak; Michael D Finch
Journal:  Arch Phys Med Rehabil       Date:  2010-02       Impact factor: 3.966

6.  Retrospective assessment of initial stroke severity with the NIH Stroke Scale.

Authors:  L S Williams; E Y Yilmaz; A M Lopez-Yunez
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

7.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

8.  Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: the Fukuoka Stroke Registry.

Authors:  Takahiro Kuwashiro; Hiroshi Sugimori; Tetsuro Ago; Masahiro Kamouchi; Takanari Kitazono
Journal:  Cerebrovasc Dis       Date:  2011-12-14       Impact factor: 2.762

9.  Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.

Authors:  Feng Qian; Gregg C Fonarow; Eric E Smith; Ying Xian; Wenqin Pan; Edward L Hannan; Benjamin A Shaw; Laurent G Glance; Eric D Peterson; Zubin J Eapen; Adrian F Hernandez; Lee H Schwamm; Deepak L Bhatt
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-05-16

10.  Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.

Authors:  Mira Katan; Felix Fluri; Nils G Morgenthaler; Philipp Schuetz; Christian Zweifel; Roland Bingisser; Klaus Müller; Stephan Meckel; Achim Gass; Ludwig Kappos; Andreas J Steck; Stefan T Engelter; Beat Müller; Mirjam Christ-Crain
Journal:  Ann Neurol       Date:  2009-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.